Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
Chirag Bavishi, Thomas M. Maddox, Franz H. Messerli
Abstract
This Viewpoint discusses recommendations for angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use in patients with or at risk of contracting coronavirus disease 2019 (COVID-19).
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Renin–angiotensin systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAngiotensin Receptor BlockersCoronavirusAngiotensin-converting enzyme 2BetacoronavirusDiseasePeptidyl-Dipeptidase AVirologyInternal medicinePharmacologyInfectious disease (medical specialty)Blood pressureOutbreakCOVID-19 Clinical Research StudiesRenin-Angiotensin System StudiesBlood Pressure and Hypertension Studies